“Tangeretin suppresses HER2-driven breast cancer via PI3K/AKT/mTOR inhibition and caspase-dependent apoptosis” (2026) Bangladesh Journal of Pharmacology, 21(1), pp. 1–10. doi:10.3329/bjp.v21i1.85717.